Increasing Prevalence of Type 2 Diabetes Mellitus in Thai Children and Adolescents Associated with Increasing Prevalence of Obesity

Size: px
Start display at page:

Download "Increasing Prevalence of Type 2 Diabetes Mellitus in Thai Children and Adolescents Associated with Increasing Prevalence of Obesity"

Transcription

1 Ο Freund Publishing House Ltd., London Journal of Pediatric Endocrinology & Metabolism, 16, 7177 (2003) Increasing Prevalence of Type 2 Diabetes Mellitus in Thai Children and Adolescents Associated with Increasing Prevalence of Obesity S. Likitmaskul, P. Kiattisathavee, K. Chaichanwatanakul, L. Punnakanta, K. Angsusingha and C. Tuchinda Division of Endocrinology and Metabolism, Department of Peditrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand ABSTRACT Type 2 diabetes mellitus (DM) is being diagnosed more frequently in children and adolescents. Thailand has a low incidence of childhood DM. This study reviewed patients with DM in the Division of Pediatric Endocrinology, Faculty of Medicine, Siriraj Hospital compared to our previous study. The results demonstrate that type 2 DM in Thai children and adolescents has increased from 5% during to 17.9% during Mean age was 11.6 years. Mean BMI was 27.8 kg/m 2. Fiftysix percent were diagnosed on routine examination. The period of increase in type 2 DM is associated with an increase of obesity prevalence from 5.8% in 1990 to 13.3% in This result emphasizes the importance of encouraging daily physical activity and healthy diet in our populations and also alerts our pediatricians and endocrinologists to the possibilities of type 2 DM in these age groups. KEY WORDS type 2 diabetes mellitus, body mass index, obesity, children, adolescents, Thailand Reprint address: Supawadee Likitmaskul, M.D. Division of Endocrinology and Metabolism Department of Pediatrics Faculty of Medicine, Siriraj Hospital Mahidol University Bangkok 10700, Thailand sislk@mahidol.ac.th INTRODUCTION Childhood and adolescent diabetes mellitus (DM) in Thailand is uncommon but not rare. During the past decade, epidemiology studies have reported a low incidence of 0.19/100,000/year during and /100,000/yearr during ' 3. However, according to our report 4, we found an increasing number of newly diagnosed cases in our center during winter and summer seasons. The classification of DM during was 93.3% type 1, 5% of type 2 and 1.7% other types 4. Interestingly, several studies have reported an increasing prevalence of type 2 DM in children and adolescents since 1990, especially in populations such as AfricanAmericans, Native Americans, Hispanics and Japanese 5 " 8. These results are concomitant with an increased prevalence of obesity 7 " 9. In Thailand, the national income has been increasing rapidly. The gross national product (GNP) has increased from 50,000 million baht in 1960, to 600,000 million baht in 1980, and to 4 million million baht in This has obviously brought about changes in our society. Owing to globalization, and imitation of youths' lifestyle around the world, especially in eating patterns and fashion, Thai society has changed from an agricultural lifestyle to an industrialized lifestyle with an increase in sedentary activities. A national nutritional assessment survey reported that the total fat content in dietary intake has increased from 8.9% of total daily calories in to 21.8% in and up to 26.3% in Meanwhile, only 5% of women and 13% of men aged between 15 and 24 years spend leisure time on outdoor activities; the rest watch television, listen to the radio, read and sleep 14. A national public health survey showed an increasing amount of overweight in all age groups; the number of overweight VOLUME 16, NO. 1,

2 72 S. LIKITMASKUL ET AL. children aged 612 years increased significantly from 5.8% in to 13.3% in These numbers varied in different types of schools, with some private schools in Bangkok (the capital city) having as many as 30% overweight pupils, as shown in Table 1. Surprisingly, even in the slum area of Bangkok, we also found 15% of children aged 615 years to be overweight in the last survey in (Table 1). These data alert us to this serious public health problem. The present study aimed to investigate whether this is a new trend in the causation of DM in Thai children and adolescents, and also to characterize the clinical manifestations of type 2 DM in Thai youth. PATIENTS AND METHODS We reviewed the medical records of patients with newly diagnosed DM aged 014 years presenting from January 1997 to December 1999 at the Endocrine Unit, Pediatric Department, Faculty of Medicine, Siriraj Hospital, Mahidol University. Patients were informed that the data were collected for an epidemiological study. The individual data at diagnosis included signs and symptoms of DM, age, weight, height, birth weight, family history of DM, hypertension and heart disease, and acanthosis nigricans. Initial laboratory investigations, including blood glucose, serum ketones, electrolytes, lipid profiles, antibodies to glutamic acid decarboxylase (GAD), insulin autoantibodies (IAA), glycosylated hemoglobin (HbAu) and insulin level, were also noted. Oral glucose tolerance tests (OGTT) were carried out in patients with type 2 DM. The types of DM were differentiated according to the report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 18 and as recommended by Rosenbloom et α/. 8. The diagnostic criteria for type 2 DM included obesity (weight for height >95 percentile for age), hyperglycemia, negative GAD and IAA antibodies, and insulin therapy not required until December 2001, and either one sign of insulin resistance (acanthosis nigricans, hypertension, hyperlipidemia) or measurable fasting insulin level. For type 1 DM, the criteria for diagnosis included hyperglycemia with ketosis plus either positive antibodies or requirement for continuing insulin therapy. Clinical manifestations at diagnosis, and initial management of type 2 DM were also recorded. Weight for height was calculated as actual weight (kg) divided by ideal weight for height on the Thai national growth chart 19 multiplied by 100. Body mass index (BMI) was calculated by weight (kg) divided by [height (m)] 2. Student's ttest was used for data analysis. TABLE 1 Prevalence of overweight in children aged 515 years in Bangkok metropolitan area during the last 10 years in relaiion to different types of school Type of school (%) Universitycontrolled schools Private schools Government schools ] 3 3 Metropolitan schools Slum area Total no. of children 1,675 2,885 2, JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

3 TYPE 2 DIABETES MELLITUS IN THAI CHILDREN 73 RESULTS There were a total of 39 patients diagnosed with DM during the study period. Twentyeight patients (71.8%) were diagnosed with type 1 DM. Seven patients (17.9%) were diagnosed with type 2 DM. Another four patients (10.3%) had other types of DM PraderWilli syndrome, systemic lupus erythematosus (SLE) and Lasparaginaseinduced diabetic ketoacidosis (DKA) during leukemia treatment (Table 2). Clinical manifestations and laboratory data of patients with type 2 and type 1 DM are shown in Table 3. Mean age at diagnosis of type 2 DM was close to the adolescent age (11.6 years old) compared to 7.8 years old in patients with type 1 DM (p = 0.001). In the type 2 group, the patients were obese; mean weight for height was 159.1% and mean BMI was 27.8 kg/m 2, compared to 107.6% (p = ) and 16.8 kg/m 2 (p <0.0001) in the type 1 group, respectively. Mean HbAi c was lower in the type 2 group at 9.5% compared to 11.9% (p = 0.08) in the type 1 group. Hypercholesterolemia and hypertriglyceridemia were frequent in both groups. GAD and IAA antibodies were not detected in the type 2 group. Acanthosis nigricans was found in 71.4% of patients with type 2 DM but not found in patients with type 1 DM. Fasting insulin levels were measured in patients with type 2 DM and the mean level was found to be 28.8 μυ/ml. DKA was found in 78% of patients with type 1 DM and 14.2% of patients with type 2 DM. Of the seven patients with type 2 DM, three were female and four were male. Six out of the seven had records of birth weight, and all birth weights were normal. One patient had no family history of DM, hypertension or heart disease. Only three patients (44%) presented with signs and symptoms of DM; two (28%) presented during acute illness (asthmatic attack and acute leukemia); the remaining two patients (28%) were detected during OGTTs as part of obesity evaluation. In the patient with leukemia, the patient had a history of weight loss and presented with DKA during L asparaginase induction for leukemia therapy. After stopping Lasparaginase, he was controlled with a diabetic diet for 3 months, after which an OGTT was carried out and found to be positive. He tested positive for both acanthosis nigricans and family history of DM. The management regimen in type 2 DM in children has been under discussion. Three patients were started with insulin injections, and discontinued by 2 weeks, after which two patients received oral antihyperglycemic drugs and one TABLE 2 Classification of childhood and adolescent diabetes mellitus (age 014 years) in the Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, during Jan 1997Dec 1999 compared to our previous study 4 Total number Type 1 DM Type 2 DM Other type of DM Cases/year Our Previous Study 4 Jan 1987Dec 1996 No. % (ßthalassemia major) 5.9 Present study Jan 1997Dec 1999 No. % :, 'V I i (PraderWilli syndrome [1], ; SLE [1], leukemia [2]) >ιλι 13.0 VOLUME 16. NO. 1,2003

4 74 S. LIK.ITMASK.UL ET AL. TABLE 3 Clinical and laboratory manifestations of type 1 and type 2 diabetes mellitus in Thai children aged 014 years Type 1 DM Type 2 DM ρ value Age at diagnosis (yr; range) 7.8 ±3.9 ( ) 11.6 ±2.1 ( ) Wt for Ht (%; range) ± 16(79146) ±21 (134194) BMI (kg/m 2 ; range) 16.8 ±2.5 (12.723) 27.8 ± 3.2 ( ) F:M 1.15:1 0.75:1 Family history of DM 57% Family history of DM or hypertension/heart disease 85% Acanthosis nigricans 0% 71.4% DKA at onset 78% 14.2% Fasting insulin (μυ/ml) 28.8 ±21 (1375) AntiGAD positive 53% 0% IAA positive 47% 0% HbA, c (%; range) 11.9 ±2.5 ( ) 9.5 ±3.6 ( ) 0.08 Cholesterol >170 mg% 68.1% 71% Triglycerides >130 mg% 33% 43% patient was diet controlled. Another four patients had initial therapy with oral antihyperglycemic agents two patients combined sulfonylurea and biguanide (metformin); two (who had no symptoms of DM and were detected during OGTT) had only biguanide (metformin). After 3 months, every patient received metformin and only two patients had this combined with sulfonylurea. No one required ongoing insulin therapy (Table 4). DISCUSSION The diagnostic criteria for type 2 DM in children are still not conclusive; clinical longterm follow up is important. However, our patients with type 2 DM were all obese, hyperglycemic, had negative antibodies, did not require ongoing insulin therapy, and had no DKA episode during follow up. They all had measurable fasting insulin levels, as shown in Table 3, and did not have any clinical characteristics of syndromes or causes for the WHO classification of 'DM of other type'. In the group diagnosed with type 1 DM, all continue to require insulin therapy until the present. The main differences between the two groups are with/without insulin therapy for blood glucose control, and negative/positive antibodies. In the type 2. DM group, HbAi c was improved by oral hypoglycemic drugs and weight control with a diet and exercise program during follow up, as shown in Table 4. Type 2 DM in children and adolescents has increased in the Thai population compared to our previous study 4, from 5% to 17.9%, as shown in Table 2. The majority of patients were in the early adolescent age group and in obese children. Acanthosis nigricans were found in 71.4% of patients. Only 44% had significant signs and symptoms of DM. Fiftysix percent were incidentally diagnosed on either routine physical JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

5 TYPE 2 DIABETES MELLITUS IN THAI CHILDREN 75 TABLE 4 Management and follow up of individual patients with type 2 diabetes mellitus Patient # Initial management Insulin injection 3d 2 wk 1 wk Sulfonylurea Metformin (mg/d) Diet control ' Continued management After 3 mo. Metformin (mg/d) Sulfonylurea + + After 1 yr Metformin (mg/d) Sulfonylurea no med. After 2 yr Metformin (mg/d) Sulfonylurea no med. Follow up HbA, c (%) Initial After 3 mo. treatment After 1 yr treatment After 2 yr treatment BMI (kg/m 2 ) Initial After 3 mo. treatment After 1 yr treatment After 2 yr treatment _ 30.4 _ 28.2 examination or during acute illness. The period of increase was concomitant with an increase in the prevalence of obesity in the country. These results support the view that an emerging epidemic of type 2 DM in the young is taking place in the Thai population. Thailand has a significantly low incidence of childhood and adolescent DM, but has a relatively high prevalence of type 2 DM in adulthood, especially at older age Therefore, we can predict that the number of patients with type 2 DM in our country will be much higher in the near VOLUME 16, NO. 1,2003

6 76 S. LIKITMASKUL ET AL. future, and related to childhood obesity. This result should alert all physicians to making differential diagnosis of type 1 and type 2 DM in the young. We suggest that it is very important to pay attention to overweight in late childhood and adolescent age, whether or not there is any sign of insulin resistance; further investigations on ßcell function or close observation for evidence of type 2 DM should be done. These results should also alert public health officials to encourage daily physical activity, less sedentary behavior, and a high fiber, low fat, low calorie diet, for future prevention of the disease. Further research directed at an understanding of the basic biology of insulin action and production as well as genetic factors of specific ethnic groups may be helpful for the future management and prevention of type 2 DM. CONCLUSIONS These data demonstrate an increase of type 2 DM in Thai children and adolescents similar to that in other countries. This result should alert pediatricians and endocrinologists to consider this diagnosis in this group of patients. ACKNOWLEDGEMENTS These data were presented at the 26 th Annual Meeting of ISPAD, Los Angeles, CA, USA, The authors wish to thank the ISPAD 2000 organizing committee for their kind support and also Ms Amornrat Pipatsathiant and Ms Tassanee Yenlukroy for their helpful assistance. REFERENCES 1. Tuchinda C, Angsusingha K, Chaichanwatanakul K, Likitmaskul S, Vanasaeng S. The epidemiology of insulin dependent diabetes mellitus (IDDM): report from Thailand. J Med Assoc Thai 1992; 75: Panamonta O, Laopaiboon M, Tuchinda C. Incidence of childhood type 1 (insulin dependent diabetes mellitus) in northeastern Thailand. J Med Assoc Thai 2000; 83: Patarakijvanich N, Tuchinda C. Incidence of diabetes mellitus type 1 in children of southern Thailand. J Med Assoc Thai 2001; 84: Likitmaskul S, Angsusingha K, Morris S, Kiattisakthavee P, Chaichanwatanakul K, Tuchinda C. Type 1 diabetes in Thai children aged 014 year. J Med Assoc Thai 1999; 82: PinhasHamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non insulin dependent diabetes mellitus among adolescents. J Pediatr 1996; 128: Neufeld ND, Raffal LJ, Landon C, Chen YDI, Vadheim CM. Early presentation of type 2 diabetes in Mexican American youth. Diabetes Care 1998; 21: Kitagawa T, Owada M, Urakami T, Yamauchi K. Increase incidence of non insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr 1998; 37: Rosenbloom AL, Young RS, Joe JR, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: Young TK, Dean HJ, Flett B, WoodSteimann P. Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr 2000; 136: National Statistical Report Bangkok: National Statistical Office, Office of Prime Minister. 11. Nutrition Survey for Thailand, OctoberDecember. Bangkok: Interdepartmental Committee on Nutrition for National Defense (ICNND); December Third National Nutrition Survey Report. Bangkok: Department of Health, Ministry of Public Health, A Study of Nutrition and Lipid Profiles in Labour and Administrative Population. Bangkok: Department of Health, Ministry of Public Health, A Study of Lifestyle in Thai Youth (aged 1524 years old) Thai Health Status. Bangkok: Institute for Population and Social Research, Mahidol University, Chittchang U. Development of simple anthropometric tools for growth monitoring in primary school children. D.Sc. Thesis (Nutrition), Mahidol University, Ruangdarakanon N. Health status in school children aged 612 years. Department of Health Survey. Bangkok: Ministry of Public Health, 1996; KlanKlin S, Asaranuruk S. Nutrition and nutritional status of school aged children in slum area, Bangkok. J Health 1999;81: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23: s4sl Chavalittamrong B, Tampradub S, Vanprapar N. Height and weight of Thai children: high socioeconomic group of some selected urban populations. J Med Assoc Thai 1989; Chaisiri K, Pongpaew P, Tungtrongchitr R, Phonrat B, Kulleap S, Kuhathong C, Suttiwong P, Intarakhao C. Prevalence of abnormal glucose tolerance in Khon Kaen province and validity of urine stick and fasting blood sugar as screening tools. J Med Assoc Thai 1997; 80: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

7 TYPE 2 DIABETES MELLITUS IN THAI CHILDREN 21. Suwanwalaikorn S, Nitiyanant W, Puavilai K. Prevalence of diabetes mellitus and impaired glucose tolerance in high risk Thai population, comparing old and new criteria for diagnosis. 11 th AsiaOceania Congress of Endocrinology, April 1998, Seoul, Korea (Abst). VOLUME 16, NO. 1,2003

8

Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the Tokyo Metropolitan Area

Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the Tokyo Metropolitan Area Clin Pediatr Endocrinol 2007; 16(2), 53-58 Copyright 2007 by The Japanese Society for Pediatric Endocrinology Original Article Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the

More information

Distinguishing T1D vs. T2D in Childhood: a case report for discussion

Distinguishing T1D vs. T2D in Childhood: a case report for discussion Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

Childhood Obesity and Type II Diabetes: A Rising Epidemic

Childhood Obesity and Type II Diabetes: A Rising Epidemic Childhood Obesity and Type II Diabetes: A Rising Epidemic Charli Oquin, MS, APRN, PNP, NCSN, CNA Presentation Texas Association of Perianesthesia Nurses (TAPAN) September, 2010 National Initiatives Addressing

More information

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology

More information

Diabetes Mellitus in the Pediatric Patient

Diabetes Mellitus in the Pediatric Patient Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions

More information

Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER

Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER Type 2 Diabetes Mellitus in Adolescents PHIL ZEITLER MD, PHD SECTION OF ENDOCRINOLOGY DEPARTMENT OF PEDIATRICS UNIVERSITY OF COLORADO DENVER Yes! Is Type 2 diabetes the same in kids as in adults? And No!

More information

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Type 1 Diabetes Mellitus in the Adult Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Diabetes Mellitus: Type I Genetic factor Sudden onset Majority children and adolescents with an increasing

More information

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions

More information

Adolescent Obesity GOALS BODY MASS INDEX (BMI)

Adolescent Obesity GOALS BODY MASS INDEX (BMI) Adolescent Obesity GOALS Lynette Leighton, MS, MD Department of Family and Community Medicine University of California, San Francisco December 3, 2012 1. Be familiar with updated obesity trends for adolescent

More information

Prevention and Management Of Obesity Adolescents & Children

Prevention and Management Of Obesity Adolescents & Children Prevention and Management Of Obesity Adolescents & Children The Pediatric Obesity Prevention and Treatment Toolkit is available at: https://www.optimahealth.com/providers/clinical-reference/pediatric-obesity-prevention-andtreatment-toolkit

More information

Blood Pressure Measurement (children> 3 yrs)

Blood Pressure Measurement (children> 3 yrs) Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic

More information

GRACE C. PAGUIA, MD DPPS DPBCN

GRACE C. PAGUIA, MD DPPS DPBCN Nutrition Dilemmas, WEIGHT MANAGEMENT IN CHILDREN AND ADOLESCENTS: THE EXISTING GUIDELINES GRACE C. PAGUIA, MD DPPS DPBCN Overweight & Obesity in Pediatrics Nutrition Dilemmas, q results from a chronic

More information

Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report

Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report Expert Committee s Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report (1) Overview material Release Date December 2007 Status Available in

More information

GLOSSARY. Blood sugar level The amount of sugar or glucose in the blood that is the source of energy for all the cells in the body.

GLOSSARY. Blood sugar level The amount of sugar or glucose in the blood that is the source of energy for all the cells in the body. GLOSSARY A1C (also known as glycosylated or glycated hemoglobin or as HbA1c). A blood test that provides the best measure of average blood sugar control for the past 2 3 months. The results provide patients

More information

DIABETES MELLITUS. IAP UG Teaching slides

DIABETES MELLITUS. IAP UG Teaching slides DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message

More information

RESIST Dietary strategies to improve insulin sensitivity in overweight adolescents

RESIST Dietary strategies to improve insulin sensitivity in overweight adolescents RESIST Dietary strategies to improve insulin sensitivity in overweight adolescents Sarah Garnett MNutDiet PhD Institute of Endocrinology and Diabetes sarah.garnett@health.nsw.gov.au Childhood obesity Australia

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

Pediatric Obesity and Chronic Disease

Pediatric Obesity and Chronic Disease Pediatric Obesity and Chronic Disease Dana Kosmala, DO Mid-Valley Pediatrics Vanessa Majeski, MS-3 Western University of Health Sciences Objectives: 1. Risk factors for developing childhood obesity 2.

More information

OBESITY IN PRIMARY CARE

OBESITY IN PRIMARY CARE OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Living Well with Diabetes

Living Well with Diabetes Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form

More information

Annual Incidence and Clinical Characteristics of Type 2 Diabetes in Children as Detected by Urine Glucose Screening in the Tokyo Metropolitan Area

Annual Incidence and Clinical Characteristics of Type 2 Diabetes in Children as Detected by Urine Glucose Screening in the Tokyo Metropolitan Area Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Annual Incidence and Clinical Characteristics of Type 2 Diabetes in Children as Detected by Urine Glucose Screening in the

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? Am I at Risk for Type Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes On this page: What is type diabetes? Can type diabetes be prevented? What are the signs and symptoms of type diabetes?

More information

Wayne Gravois, MD August 6, 2017

Wayne Gravois, MD August 6, 2017 Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion

More information

/07/ PEDIATRIC RESEARCH Vol. 61, No. 2, 2007 Copyright 2007 International Pediatric Research Foundation, Inc.

/07/ PEDIATRIC RESEARCH Vol. 61, No. 2, 2007 Copyright 2007 International Pediatric Research Foundation, Inc. 0031-3998/07/6102-0141 PEDIATRIC RESEARCH Vol. 61, No. 2, 2007 Copyright 2007 International Pediatric Research Foundation, Inc. Printed in U.S.A. REVIEW ARTICLE Urine Glucose Screening Program at Schools

More information

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral

More information

Non-type 1 diabetes mellitus in Canadian children

Non-type 1 diabetes mellitus in Canadian children Non-type 1 diabetes mellitus in Canadian children Principal investigators Shazhan Amed, MD, FRCPC, FAAP, Division of Endocrinology, The Hospital for Sick Children, 555 University Ave, Toronto ON M5G 1X8;

More information

Screening for diabetes

Screening for diabetes Screening for diabetes Peggy Odegard, Pharm.D, BCPS, CDE What are your risks? 1 Diabetes Mellitus A problem with glucose regulation type 1= pancreas cannot produce insulin so total insulin deficiency,

More information

Children s Fitness and Access to Physical Activity Facilities

Children s Fitness and Access to Physical Activity Facilities Cavnar, Yin, Barbeau 1 Children s Fitness and Access to Physical Activity Facilities Marlo Michelle Cavnar, MPH 1, Zenong Yin, PhD 1, Paule Barbeau, PhD 1 1 Medical College of Georgia, Georgia Prevention

More information

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates Juan Pablo Frias, MD President and CEO, National Research Institute, Los Angeles, CA Clinical Faculty, University

More information

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS DIABETES MELLITUS 1. Introduction Diabetes is a global epidemic with 415 million people affected worldwide equivalent to the total population of the USA, Canada and Mexico. In recognition of this, the

More information

EFFECTIVENESS OF DM WONDER TRIP A NEW EDUCATIONAL TOOL FOR TYPE 1 DIABETES

EFFECTIVENESS OF DM WONDER TRIP A NEW EDUCATIONAL TOOL FOR TYPE 1 DIABETES EFFECTIVENESS OF DM WONDER TRIP A NEW EDUCATIONAL TOOL FOR TYPE 1 DIABETES Usanee Leelapreechalert 1, Chatrapa Hudthagosol 3, Jeerunda Santiprabhob 1,2, Pairunyar Nakavachara 1 and Supawadee Likitmaskul

More information

Media centre Obesity and overweight

Media centre Obesity and overweight 1 of 5 06/05/2016 4:54 PM Media centre Obesity and overweight Fact sheet N 311 Updated January 2015 Key facts Worldwide obesity has more than doubled since 1980. In 2014, more than 1.9 billion adults,

More information

The changes of subtypes in pediatric diabetes and their clinical and laboratory characteristics over the last 20 years

The changes of subtypes in pediatric diabetes and their clinical and laboratory characteristics over the last 20 years Original article http://dx.doi.org/10.6065/apem.2016.21.2.81 Ann Pediatr Endocrinol Metab 2016;21:81-85 The changes of subtypes in pediatric diabetes and their clinical and laboratory characteristics over

More information

Evaluation and Treatment of Childhood Obesity

Evaluation and Treatment of Childhood Obesity Evaluation and Treatment of Childhood Obesity Stephen R. Daniels, MD, PhD Department of Pediatrics University of Colorado School of Medicine and Children s Hospital Colorado In 1953, Morris et al compared

More information

The prevalence of obesity in adults has doubled over the past 30 years

The prevalence of obesity in adults has doubled over the past 30 years Obesity in America: Facts and Fiction MICHAEL G. PERRI, PhD Professor, Clinical and Health Psychology Interim Dean, College of Public Health and Health Professions University of Florida Overview: Key Questions

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Clinical Study Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome

Clinical Study Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome Cholesterol Volume 2012, Article ID 961410, 5 pages doi:10.1155/2012/961410 Clinical Study Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with

More information

Differing clinical features in Aboriginal vs. non-aboriginal children presenting with type 2 diabetes

Differing clinical features in Aboriginal vs. non-aboriginal children presenting with type 2 diabetes Pediatric Diabetes 2012 doi: 10.1111/j.1399-5448.2012.00859.x All rights reserved 2012 John Wiley & Sons A/S Pediatric Diabetes Original Article Differing clinical features in Aboriginal vs. non-aboriginal

More information

Common Diabetes-related Terms

Common Diabetes-related Terms Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes

More information

An important obstacle to the assessment of the prevalence of overweight and obesity in

An important obstacle to the assessment of the prevalence of overweight and obesity in According to the World Health Organization (WHO), adolescents comprise about 19% of the world s population (approximately 1.2 billion people), yet adolescents remain a largely neglected, difficult-to-measure,

More information

OBESITY. SEARCH Program Southwest Community Health Center Grace Hwang, RN, SPNP Yale University SON

OBESITY. SEARCH Program Southwest Community Health Center Grace Hwang, RN, SPNP Yale University SON OBESITY SEARCH Program Southwest Community Health Center Grace Hwang, RN, SPNP Yale University SON BACKGROUND: STATISTICS 1 in 4 children in U.S.

More information

Other Ways to Achieve Metabolic Control

Other Ways to Achieve Metabolic Control Other Ways to Achieve Metabolic Control Nestor de la Cruz- Muñoz, MD, FACS Associate Professor of Clinical Surgery Chief, Division of Laparoendoscopic and Bariatric Surgery DeWitt Daughtry Family Department

More information

51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD

51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD 51 year old woman with hyperglycemia August 9, 2012 Katie Stanley, MD HPI Diagnosed with DM 1 year prior to visit Established primary care at that time due to notable weight loss after tobacco cessation

More information

Analysis Plan Submission Form

Analysis Plan Submission Form Analysis Plan Submission Form DMHT : Analysis Plan #00410222 Date submitted: 03 January 2014 at 15:19:09 Date approved: Analysis Plan Title: Achievement of metabolic goals among different health insurance

More information

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona Lessons from conducting research in an American Indian community: The Pima Indians of Arizona Peter H. Bennett, M.B., F.R.C.P. Scientist Emeritus National Institute of Diabetes and Digestive and Kidney

More information

Investigators, study sites Multicenter, 35 US sites. Coordinating Investigator: Richard Bergenstal, MD

Investigators, study sites Multicenter, 35 US sites. Coordinating Investigator: Richard Bergenstal, MD STUDY SYNOPSIS Study number Title HMR1964A/3502 Apidra (insulin glulisine) administered in a fixed-bolus regimen vs. variable-bolus regimen based on carbohydrate counting in adult subjects with type 2

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Copyright. Ayoade Olayemi Adeyemi

Copyright. Ayoade Olayemi Adeyemi Copyright By Ayoade Olayemi Adeyemi 2011 The Thesis Committee for Ayoade Olayemi Adeyemi Certifies that this is the approved version of the following thesis: Adherence to oral antidiabetic medications

More information

session Introduction to Eat Well & Keep Moving

session Introduction to Eat Well & Keep Moving session 1 Introduction to Eat Well & Keep Moving Overview of Workshop Session 1: Introduction to Eat Well & Keep Moving Session 2: The Good Life Wellness Session 3: Eat Well & Keep Moving Principles of

More information

associated with serious complications, but reduce occurrences with preventive measures

associated with serious complications, but reduce occurrences with preventive measures Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

Childhood Obesity Epidemic- African American Community

Childhood Obesity Epidemic- African American Community Childhood Obesity Epidemic- African American Community Link D Juanna Satcher MD MPH Assistant Professor of Pediatrics Baylor College of Medicine Gulf Coast Apollo Chapter Objectives Summarize obesity rates

More information

Original Article. Keiko KOHNO 1), Kazuhiko HOSHI 1), Motoi TAKIZAWA 1), Takashi KANEKO 2), and Shuji HIRATA 1)

Original Article. Keiko KOHNO 1), Kazuhiko HOSHI 1), Motoi TAKIZAWA 1), Takashi KANEKO 2), and Shuji HIRATA 1) Yamanashi Med. J. 21(3), 53 ~ 58, 2006 Original Article Usefulness of the 50-g Glucose Challenge Test for Screening of Patients with Gestational Diabetes Mellitus and an Analysis of the Timing of Administration

More information

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ

ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ ATHLETES & PRESCRIBING PHYSICIANS PLEASE READ USADA can grant a Therapeutic Use Exemption (TUE) in compliance with the World Anti- Doping Agency International Standard for TUEs. The TUE application process

More information

March 23-25, 2017 Certificate of Training in Childhood and Adolescent Weight Management Post-Test

March 23-25, 2017 Certificate of Training in Childhood and Adolescent Weight Management Post-Test March 23-25, 2017 Certificate of Training in Childhood and Adolescent Weight Management Post-Test The post-test must be completed no later than midnight on Monday, April 10, 2017. The posttest consists

More information

Case study: Lean adult with no complications, newly diagnosed with type 2 diabetes

Case study: Lean adult with no complications, newly diagnosed with type 2 diabetes Case study: Lean adult with no complications, newly diagnosed with type 2 diabetes Authored by Clifford Bailey and James LaSalle on behalf of the Global Partnership for Effective Diabetes Management. The

More information

The Characteristics and Needs of Children and Adolescents Diagnosed with Type 2 Diabetes Mellitus in Santa Clara County, California

The Characteristics and Needs of Children and Adolescents Diagnosed with Type 2 Diabetes Mellitus in Santa Clara County, California S. M. Orzech. et al. / Californian Journal of Health Promotion 00, Volume, Issue, 0- The Characteristics and Needs of Children and Adolescents Diagnosed with Type Diabetes Mellitus in Santa Clara County,

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for Type 2 Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS

METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University

More information

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and

More information

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes A randomized, single-blind comparative study MICHAEL

More information

The U.S. Obesity Epidemic: Causes, Consequences and Health Provider Response. Suzanne Bennett Johnson 2012 APA President

The U.S. Obesity Epidemic: Causes, Consequences and Health Provider Response. Suzanne Bennett Johnson 2012 APA President The U.S. Obesity Epidemic: Causes, Consequences and Health Provider Response Suzanne Bennett Johnson 2012 APA President sbjohnson@apa.org Presentation Overview Epidemiology of obesity Consequences of obesity

More information

Running head: PEDIATRIC TYPE II DIABETES 1. Pediatric Type II Diabetes Mellitus: Examining the Upward Trend. Allison Foering

Running head: PEDIATRIC TYPE II DIABETES 1. Pediatric Type II Diabetes Mellitus: Examining the Upward Trend. Allison Foering Running head: PEDIATRIC TYPE II DIABETES 1 Pediatric Type II Diabetes Mellitus: Examining the Upward Trend Allison Foering A Senior Thesis submitted in partial fulfillment of the requirements for graduation

More information

Obesity in the US: Understanding the Data on Disparities in Children Cynthia Ogden, PhD, MRP

Obesity in the US: Understanding the Data on Disparities in Children Cynthia Ogden, PhD, MRP Obesity in the US: Understanding the Data on Disparities in Children Cynthia Ogden, PhD, MRP National Center for Health Statistics Division of Health and Nutrition Examination Surveys Obesity in the US,

More information

Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1

Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1 Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus Bruce Knutsen, MD Michael Slag, MD Lisa Thomas, RN, CDE Essentia Health Diabetes and Endocrinology Conference October 14, 2011 History

More information

Shifting Paradigms Treating Pediatric Obesity

Shifting Paradigms Treating Pediatric Obesity Shifting Paradigms Treating Pediatric Obesity Colony S. Fugate, D.O. Clinical Associate Professor of Pediatrics Oklahoma State University Center for Health Sciences Medical Director, Family Health and

More information

Changing Diabetes: The time is now!

Changing Diabetes: The time is now! Midwest Cardiovascular Research Foundation Welcomes DANITA HARRISON, ARNP Ms. Harrison discloses speaking relationships with Lilly, Novo Nordisk and Pfizer. Changing Diabetes: The time is now! Danita Harrison

More information

Case Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

Case Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus Case Reports in Pediatrics Volume 2013, Article ID 703925, 4 pages http://dx.doi.org/10.1155/2013/703925 Case Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes

More information

DISCLOSURES: 8/27/18 USE OF A SHARED MEDICAL APPOINTMENT FOR PEDIATRIC OBESITY

DISCLOSURES: 8/27/18 USE OF A SHARED MEDICAL APPOINTMENT FOR PEDIATRIC OBESITY DISCLOSURES: Nothing to disclose USE OF A SHARED MEDICAL APPOINTMENT FOR PEDIATRIC OBESITY Catherine Lux, DNP,RN,CPNP-PC https://encrypted-tbn0.gstatic.com/images?q=tbn:and9gcrafxzs7e6tfxm2vxdjdp9fmkun25ryuuyqimh2f4zgg2df_gs_sq

More information

Text-based Document. Predicting Factors of Body Fat of Metabolic Syndrome Persons. Downloaded 13-May :51:47.

Text-based Document. Predicting Factors of Body Fat of Metabolic Syndrome Persons. Downloaded 13-May :51:47. The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based

More information

第十五章. Diabetes Mellitus

第十五章. Diabetes Mellitus Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances

More information

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program NATIONAL COST OF OBESITY SEMINAR Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program 1 INTRODUCTION According to the Center of Disease Control and Prevention, the American society

More information

Childhood Obesity. Examining the childhood obesity epidemic and current community intervention strategies. Whitney Lundy

Childhood Obesity. Examining the childhood obesity epidemic and current community intervention strategies. Whitney Lundy Childhood Obesity Examining the childhood obesity epidemic and current community intervention strategies Whitney Lundy wmlundy@crimson.ua.edu Introduction Childhood obesity in the United States is a significant

More information

Presenter Disclosure Information

Presenter Disclosure Information Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure

More information

Obesity Prevention and Treatment at Well Child Visits

Obesity Prevention and Treatment at Well Child Visits Obesity Prevention and Treatment at Well Child Visits The Evidence-Based Approach to Clinical Care Susma Vaidya, MD Yolandra Hancock, MD Obesity Institute @ Children s National November 2, 2011 Today we

More information

THE PREVALENCE OF OVERweight

THE PREVALENCE OF OVERweight ORIGINAL CONTRIBUTION Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000 Cynthia L. Ogden, PhD Katherine M. Flegal, PhD Margaret D. Carroll, MS Clifford L. Johnson, MSPH THE

More information

METABOLIC CONSEQUENCES OF CHILDHOOD OBESITY

METABOLIC CONSEQUENCES OF CHILDHOOD OBESITY METABOLIC CONSEQUENCES OF CHILDHOOD OBESITY Suttipong Wacharasindhu Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Lifestyle changes are among the many factors

More information

ISSN X (Print) Research Article. *Corresponding author P. Raghu Ramulu

ISSN X (Print) Research Article. *Corresponding author P. Raghu Ramulu Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2014; 2(1B):133-137 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources)

More information

Analysis of Duke s Healthy Lifestyles Program: A Reimbursable, Sustainable Monthly Intervention For Overweight and Obese Children.

Analysis of Duke s Healthy Lifestyles Program: A Reimbursable, Sustainable Monthly Intervention For Overweight and Obese Children. Analysis of Duke s Healthy Lifestyles Program: A Reimbursable, Sustainable Monthly Intervention For Overweight and Obese Children By Elizabeth Reese A Master s Paper submitted to the faculty of the University

More information

Region VI. Health Initiative Overview

Region VI. Health Initiative Overview Region VI Health Initiative Overview National Health Committee Region VI Health and Wellness Coordinators Chapters Objectives Health Awareness Health Disparities Education Prevention Health Focus of the

More information

Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013

Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013 Original Article www.cmj.ac.kr Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013 Tae Hyun Park 1, Min Sun Kim 1,2, * and Dae-Yeol Lee 1,2 1

More information

Obesity Medicine for the Adolescent Patient: It Takes The Village

Obesity Medicine for the Adolescent Patient: It Takes The Village Obesity Medicine for the Adolescent Patient: It Takes The Village Topic: The Biology of Adolescent Sleep; Chronic Pain and Adolescents; Adolescents and Obesity ATLANTIC REGIONAL OSTEOPATHIC CONVENTION,

More information

CE on SUNDAY Newark, NJ October 18, 2009

CE on SUNDAY Newark, NJ October 18, 2009 CE on SUNDAY Newark, NJ October 18, 2009 Date: Sunday, October 18, 2009 Time: 2:45 PM 3:45 PM Location: Sheraton Newark Airport Hotel Title: Speaker(s): Addressing Challenges in Type 2 Diabetes ACPE #

More information

It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children

It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children Robert Ratner, M.D., F.A.C.P. Vice President for Scientific Affairs, Medstar Research Institute

More information

Incidence trends of type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children

Incidence trends of type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children Incidence trends of type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children A comparison Canadian Paediatric Surveillance Program study one decade later Principal investigators

More information

Addressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:

Addressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker: Addressing Challenges in Type 2 Diabetes Geneva Briggs, PharmD,, BCPS Addressing Challenges in Type 2 Diabetes Speaker: Dr. Geneva Clark Briggs, a board-certified Pharmacotherapy Specialist, received her

More information

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011 Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled

More information

Study Code: Date: 27 July 2007

Study Code: Date: 27 July 2007 These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:

More information

Know Your Numbers Your Most Vital Statistic

Know Your Numbers Your Most Vital Statistic Know Your Numbers Your Most Vital Statistic 1 Know Your Numbers This presentation is meant to be educational. The goal of this presentation is to help you become a better health care consumer. Always ask

More information

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of

More information

University Journal of Medicine and Medical Specialities

University Journal of Medicine and Medical Specialities ISSN 2455-2852 2019, Vol. 5(1) A STUDY ON PREVALENCE OF OVERWEIGHT AND OBESITY AND FACTORS INFLUENCING OBESITY AMONG SCHOOL GOING ADOLESCENTS IN CHENNAI, 2016 Author :KARTHICK B Department of PUBLIC HEALTH,MADRAS

More information

Obesity in Thai Adolescents: Lifestyles, Health Attitudes and Psychosocial Concerns

Obesity in Thai Adolescents: Lifestyles, Health Attitudes and Psychosocial Concerns SIRIRAJ MEDICAL LIBRARY OriginalArticle Obesity in Thai Adolescents: Lifestyles, Health Attitudes and Psychosocial Concerns Supinya In-iw, M.D., Sureelak Suchritpongsa, M.D., Boonying Manaboriboon, M.D.,

More information

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson

More information

DIABETES. A growing problem

DIABETES. A growing problem DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought

More information